Skip to main content
. Author manuscript; available in PMC: 2013 Jul 25.
Published in final edited form as: Ann Intern Med. 2012 Aug 21;157(4):242–250. doi: 10.7326/0003-4819-157-4-201208210-00004

Appendix Table 3.

Patient Risk Classification, by Status

Absolute Risk
Threshold
Risk Group EUELC (n= 1868)
Harvard (n= 2922)
LLPC (n= 7652)
Case Patients
(n= 585)
n (%)
Control Participants
(n= 1283)
n (%)
Case Patients
(n= 1738)
n (%)
Control Participants
(n= 1184)
n (%)
With Disease
(n= 420)
n (%)
Disease-Free
(n= 7232)
n (%)
2.5% <2.5% 262 (44.8) 895 (69.8) 613 (35.3) 865 (73.1) 108 (25.7) 4873 (67.4)
≥2.5% 323 (55.2) 388 (30.2) 1125 (64.7) 319 (26.9) 312 (74.3) 2359 (32.6)

5.0% <5.0% 376 (64.3) 1082 (84.3) 880 (50.6) 1031 (87.1) 179 (42.6) 5867 (81.1)
≥5.0% 209 (35.7) 201 (15.7) 858 (49.4) 153 (12.9) 241 (57.4) 1365 (18.9)

10.0% <10.0% 502 (85.8) 1210 (94.3) 1299 (74.7) 1133 (95.7) 303 (72.1) 6690 (92.5)
≥10.0% 83 (14.2) 73 (5.7) 439 (25.3) 51 (4.3) 117 (27.9) 542 (7.5)

EUELC — European Early Lung Cancer; LLPC = Liverpool Lung Project prospective cohort.